Cyclohexanepropanol, 2,2,6-trimethyl-alpha-propyl-
Common Name: |
Cyclohexanepropanol, 2,2,6-trimethyl-alpha-propyl- |
IUPAC Name: |
1-(2,2,6-trimethylcyclohexyl)hexan-3-ol |
Molecular Formula: |
C15H30O |
SMILES: |
CCCC(CCC1C(CCCC1(C)C)C)O |
Inchi: |
1S/C15H30O/c1-5-7-13(16)9-10-14-12(2)8-6-11-15(14,3)4/h12-14,16H,5-11H2,1-4H3 |
Inchi Key: |
BVDMQAQCEBGIJR-UHFFFAOYSA-N |
Cas No: |
70788-30-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
226.40 |
Mass (g/mol) |
226.23 |
Molar Refractivity |
73.01 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
278.00 to 279.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.000469 |
Vapor Density (Air =1) |
7.9 |
Fraction Csp3 |
1.00 |
LogP |
4.39 |
iLOGP |
3.50 |
XLOGP3 |
5.21 |
WLOGP |
4.39 |
MLOGP |
3.81 |
ESOL Log S |
-4.20 |
ESOL Solubility (mg/ml) |
0.014 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.38 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.72 |
Silicos-IT Solubility (mg/ml) |
0.04 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-3.98 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.181 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.041 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |